Andrew J. Cowan

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial”.

γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial

The Lancet Oncology(2023)10.1016/s1470-2045(23)00246-2

N/A

2.5DataRank · unranked

101 citations

Margot J. Pont, Blythe Sather, Cameron J. Turtle, Brian G. Till, Edward N. Libby +15 more

Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study

The Lancet Haematology(2021)10.1016/s2352-3026(21)00170-8

N/A

1.6DataRank · unranked

59 citations

Ryan D. Cassaday, Stephen D. Smith, Jonathan R. Fromm, Andrew J. Cowan, Edus H. Warren +15 more

Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

Blood(2024)10.1182/blood.2024025939

N/A

0.621DataRank · unranked

10 citations

Rachael Sexton, Andrew J. Cowan, Aaron S. Rosenberg, Sikander Ailawadhi, S. Vincent Rajkumar +9 more

Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL

Blood Advances(2022)10.1182/bloodadvances.2022008628

N/A

0.240DataRank · unranked

3 citations

Ryan C. Lynch, Chaitra S. Ujjani, Ted Gooley, Heather Rasmussen, David G. Coffey +9 more

High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma

JCO Precision Oncology(2021)10.1200/po.20.00442

N/A

0DataRank · unranked

16 citations

Andrew J. Cowan, Bret DeGraaff, Timothy J. Martins, Niall Curley, Damian J. Green +9 more

Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy

medRxiv(2021)10.1101/2021.05.10.21256634

N/A

0DataRank · unranked

7 citations

Andrea N. Loes, Kiel Shuey, Elizabeth M. Krantz, Jim Boonyaratanakornkit, Jacob Keane-Candib +13 more

Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.03.005

N/A

0DataRank · unranked

42 citations

Margot J. Pont, Sayan Dasgupta, Xiaoling Song, Sushma Thomas, Gregory Pepper +10 more

Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.04.001

N/A

0DataRank · unranked

140 citations

Emily C. Liang, Qian Wu, Jenna Voutsinas, Pere Barba, Gloria Iacoboni +19 more

Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up

Clinical Lymphoma Myeloma & Leukemia(2023)10.1016/j.clml.2023.10.002

N/A

0DataRank · unranked

12 citations

Ajay K. Gopal, Brian G. Till, Mazyar Shadman, Ryan C. Lynch, Andrew J. Cowan +10 more

Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians

Blood Cancer Journal(2023)10.1038/s41408-023-00937-0

N/A

0DataRank · unranked

11 citations

Bo Wang, Larry D. Anderson, Georgia McCaughan, Nikita Mehra, Andrew J. Cowan +3 more

Who goes first? Patterns of cancer drug approvals across four major regulatory authorities: EMA, FDA, Health Canada, and PMDA.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.149

N/A

0DataRank · unranked

2 citations

Sanjay Mishra, Matthew J. Hadfield, Bishal Gyawali, Andrew J. Cowan, Ali Raza Khaki +3 more

Long-term efficacy and safety of pembrolizumab with R-CHOP as first-line therapy for DLBCL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7561

N/A

0DataRank · unranked

1 citations

Jonathan R. Fromm, Min Fang, Brian G. Till, Mazyar Shadman, Andrew J. Cowan +11 more

Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapy

Blood(2024)10.1182/blood.2024025231

N/A

0DataRank · unranked

15 citations

Pinar Ataca Atilla, Erden Atilla, Ola Landgren, Andrew J. Cowan, Sylvain Simon +6 more

Development and validation of predictive models of early immune effector cell–associated hematotoxicity

Blood Advances(2024)10.1182/bloodadvances.2024014455

N/A

0DataRank · unranked

10 citations

Jennifer J. Huang, Andrew J. Portuguese, Valentín Ortiz‐Maldonado, Aya Albittar, Natalie Wuliji +28 more

Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients

Blood(2024)10.1182/blood.2024024145

N/A

0DataRank · unranked

19 citations

Elizabeth M. Krantz, Hu Xie, Sarah Ibrahimi, Erika S. Kiem, Mandeep K Sekhon +13 more

Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis

Scientific Reports(2020)10.1038/s41598-020-73466-6

N/A

0DataRank · unranked

4 citations

Elizabeth A. Sigworth, Adrianne H. Wu, Jess Behrens, Shervin Etemad, Seema Nagpal +28 more

Influence of B cell or plasma cell-targeted CAR-T cell therapy on humoral immunity and vaccine immunogenicity: The HICAR study

Research Square(2025)10.21203/rs.3.rs-7061163/v1

N/A

0DataRank · unranked

0 citations

Stosh Ozog, Elizabeth M. Krantz, Karyn Tindbaek, Julián B. Muñoz, Winnie Liu +16 more

Assessment of Left Ventricular, Right Ventricular, and Left Atrial Strain in Light-Chain Amyloidosis

JACC CardioOncology(2020)10.1016/j.jaccao.2020.09.002

N/A

0DataRank · unranked

4 citations

Alexi Vasbinder, Hans Huang, Robin Fernandes, Andrew J. Cowan, Ajay K. Gopal +4 more

Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies

JCI Insight(2021)10.1172/jci.insight.146743

N/A

0DataRank · unranked

62 citations

Elizabeth M. Krantz, Joyce Maalouf, Jim Boonyaratanakornkit, Jacob Keane-Candib, Laurel Joncas-Schronce +13 more

Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational study

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003428

N/A

0DataRank · unranked

45 citations

Andrea N. Loes, Kiel Shuey, Elizabeth M. Krantz, Jim Boonyaratanakornkit, Jacob Keane-Candib +13 more